MTAP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.418200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.601800E-01
Normal-vs-Stage2
6.178400E-01
Normal-vs-Stage3
2.727400E-01
Normal-vs-Stage4
5.709800E-01
Stage1-vs-Stage2
9.638800E-01
Stage1-vs-Stage3
4.167400E-01
Stage1-vs-Stage4
4.302000E-01
Stage2-vs-Stage3
5.718400E-01
Stage2-vs-Stage4
4.308800E-01
Stage3-vs-Stage4
3.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.238800E-01
Normal-vs-AfricanAmerican
5.206600E-01
Normal-vs-Asian
1.338310E-02
Caucasian-vs-AfricanAmerican
3.761200E-01
Caucasian-vs-Asian
8.313500E-02
AfricanAmerican-vs-Asian
4.110400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.483800E-01
Normal-vs-Female
1.881790E-01
Male-vs-Female
6.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.429830E-01
Normal-vs-Age(41-60Yrs)
2.484400E-01
Normal-vs-Age(61-80Yrs)
4.991600E-01
Normal-vs-Age(81-100Yrs)
9.413600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.215800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.850600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.352200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.827800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.649000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.431800E-01
Normal-vs-Daily Drinker
2.780200E-01
Normal-vs-Weekly Drinker
5.908400E-01
Normal-vs-Occasional Drinker
2.986600E-01
Normal-vs-Social Drinker
6.479000E-01
Non Drinker-vs-Daily Drinker
9.283800E-01
Non Drinker-vs-Weekly Drinker
6.931400E-01
Non Drinker-vs-Occasional Drinker
9.633200E-01
Non Drinker-vs-Social Drinker
2.822000E-01
Daily Drinker-vs-Weekly Drinker
6.522600E-01
Daily Drinker-vs-Occasional Drinker
9.687000E-01
Daily Drinker-vs-Social Drinker
2.918800E-01
Weekly Drinker-vs-Occasional Drinker
6.631200E-01
Weekly Drinker-vs-Social Drinker
4.997000E-01
Occasional Drinker-vs-Social Drinker
3.066800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.669800E-01
Normal-vs-Grade 2
8.455000E-01
Normal-vs-Grade 3
6.811800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.258300E-02
Grade 1-vs-Grade 3
6.403900E-03
Grade 1-vs-Grade 4
6.669800E-01
Grade 2-vs-Grade 3
2.441400E-01
Grade 2-vs-Grade 4
8.455000E-01
Grade 3-vs-Grade 4
6.811800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.068000E-01
Normal-vs-NonDiabetic
1.341350E-01
Diabetic-vs-NonDiabetic
8.781800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.391000E-01
Normal-vs-NoPancreatitis
2.800200E-01
Pancreatitis-vs-NoPancreatitis
7.246800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.806200E-01
Normal-vs-N1
5.650400E-01
N0-vs-N1
7.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.386500E-02
Normal-vs-TP53-NonMutant
5.390400E-01
TP53-Mutant-vs-TP53-NonMutant
2.847600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
